A newly identified myokine: irisin, and its relationship with chronic spontaneous urticaria and inflammation
暂无分享,去创建一个
[1] H. Hori,et al. Chronic urticaria with inflammation. , 2020, European journal of internal medicine.
[2] I. Altunay,et al. Serum irisin level, insulin resistance, and lipid profiles in patients with hidradenitis suppurativa: a case-control study⋆⋆⋆ , 2020, Anais brasileiros de dermatologia.
[3] R. Dursun,et al. Clinical and laboratory assessment for the inflammation role in chronic spontaneous urticaria: A clinical study , 2020 .
[4] M. Ozturk,et al. How does omalizumab affect the immunoinflammatory response in patients with chronic spontaneous urticaria? , 2020, Cutaneous and ocular toxicology.
[5] M. Maurer,et al. New treatments for chronic urticaria. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[6] S. Darougar,et al. The Relationship Between Serum Interleukin-6 Level and Chronic Urticaria , 2018, Immunoregulation.
[7] T. Zuberbier,et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria , 2018, Allergy.
[8] M. Abdollahi,et al. A glance at the therapeutic potential of irisin against diseases involving inflammation, oxidative stress, and apoptosis: An introductory review. , 2018, Pharmacological research.
[9] M. Maurer,et al. The Urticaria Activity Score-Validity, Reliability, and Responsiveness. , 2017, The journal of allergy and clinical immunology. In practice.
[10] M. Świderska,et al. Serum irisin levels in patients with psoriasis , 2017, The Journal of dermatological treatment.
[11] G. Dogan,et al. Association between insulin resistance and serum and salivary irisin levels in patients with psoriasis vulgaris , 2017 .
[12] A. Gastaldelli,et al. Increased FNDC5/Irisin expression in human hepatocellular carcinoma , 2017, Peptides.
[13] G. Artaş,et al. Irisin immunostaining characteristics of breast and ovarian cancer cells. , 2016, Cellular and molecular biology.
[14] S. Canpolat,et al. Investigation of the expression of irisin and some cachectic factors in mice with experimentally induced gastric cancer. , 2016, QJM : monthly journal of the Association of Physicians.
[15] A. Kazez,et al. Irisin immunohistochemistry in gastrointestinal system cancers , 2016, Biotechnic & histochemistry : official publication of the Biological Stain Commission.
[16] Ş. Arslan,et al. Novel myokine: irisin may be an independent predictor for subclinic atherosclerosis in Behçet's disease , 2016, Journal of Investigative Medicine.
[17] J. Kasperski,et al. The Association between Platelet Count and Acute Phase Response in Chronic Spontaneous Urticaria , 2014, BioMed research international.
[18] Hae‐Sim Park,et al. Molecular Genetic Mechanisms of Chronic Urticaria , 2013, Allergy, asthma & immunology research.
[19] Zheng Chen,et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. , 2013, Journal of hepatology.
[20] Jian-jun Liu,et al. Lower circulating irisin is associated with type 2 diabetes mellitus. , 2013, Journal of diabetes and its complications.
[21] Chao-Yung Wang,et al. Decrease in Irisin in Patients with Chronic Kidney Disease , 2013, PloS one.
[22] In-kyu Lee,et al. Serum irisin levels in new-onset type 2 diabetes. , 2013, Diabetes research and clinical practice.
[23] Mary T. Brinkoetter,et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. , 2012, Metabolism: clinical and experimental.
[24] J. I. Castillo-Quan. From white to brown fat through the PGC-1α-dependent myokine irisin: implications for diabetes and obesity , 2012, Disease Models & Mechanisms.
[25] B. Spiegelman,et al. A PGC1α-dependent myokine that drives browning of white fat and thermogenesis , 2012, Nature.
[26] Shingo,et al. A PGC1-\(\alpha\)-dependent Myokine that Drives Brown-fat-like Development of White Fat and Thermogenesis , 2012 .
[27] A. Marzano,et al. Plasma levels of matrix metalloproteinase‐9 in chronic urticaria patients correlate with disease severity and C‐reactive protein but not with circulating histamine‐releasing factors , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[28] M. Sticherling,et al. Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. , 1999, The Journal of allergy and clinical immunology.
[29] S. Tarlo,et al. Chronic Urticaria , 1991, International journal of dermatology.